Bowen DM - Search Results

1

Tacrine, a drug with therapeutic potential for dementia: post-mortem biochemical evidence.

Francis PT, Bowen DM. Francis PT, et al. Among authors: bowen dm. Can J Neurol Sci. 1989 Nov;16(4 Suppl):504-10. doi: 10.1017/s031716710002984x. Can J Neurol Sci. 1989. PMID: 2572313 Review.

2

Topographical distribution of neurochemical changes in Alzheimer's disease.

Procter AW, Lowe SL, Palmer AM, Francis PT, Esiri MM, Stratmann GC, Najlerahim A, Patel AJ, Hunt A, Bowen DM. Procter AW, et al. Among authors: bowen dm. J Neurol Sci. 1988 Apr;84(2-3):125-40. doi: 10.1016/0022-510x(88)90118-9. J Neurol Sci. 1988. PMID: 2898011

3

Are post-mortem biochemical studies of human brain worthwhile?

Palmer AM, Lowe SL, Francis PT, Bowen DM. Palmer AM, et al. Among authors: bowen dm. Biochem Soc Trans. 1988 Aug;16(4):472-5. doi: 10.1042/bst0160472. Biochem Soc Trans. 1988. PMID: 2905309 No abstract available.

4

Neurotransmitters and second messengers in aging and Alzheimer's disease.

Francis PT, Webster MT, Chessell IP, Holmes C, Stratmann GC, Procter AW, Cross AJ, Green AR, Bowen DM. Francis PT, et al. Among authors: bowen dm. Ann N Y Acad Sci. 1993 Sep 24;695:19-26. doi: 10.1111/j.1749-6632.1993.tb23021.x. Ann N Y Acad Sci. 1993. PMID: 7902054 Review.

5

A glycine site as therapeutic target.

Francis PT, Procter AW, Bowen DM. Francis PT, et al. Among authors: bowen dm. Ann N Y Acad Sci. 1991;640:184-8. doi: 10.1111/j.1749-6632.1991.tb00214.x. Ann N Y Acad Sci. 1991. PMID: 1663714 Review. No abstract available.

6

Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortem.

Francis PT, Poynton A, Lowe SL, Najlerahim A, Bridges PK, Bartlett JR, Procter AW, Bruton CJ, Bowen DM. Francis PT, et al. Among authors: bowen dm. Brain Res. 1989 Aug 14;494(2):315-24. doi: 10.1016/0006-8993(89)90600-8. Brain Res. 1989. PMID: 2570624

7

Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.

Bowen DM, Najlerahim A, Procter AW, Francis PT, Murphy E. Bowen DM, et al. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9504-8. doi: 10.1073/pnas.86.23.9504. Proc Natl Acad Sci U S A. 1989. PMID: 2574463 Free PMC article.

8

Pyramidal neuron loss and "glycine-site therapy": a need for an animal model and study in late-life depression.

Bowen DM, Francis PT, Lowe SL, Pangalos MN, Procter AW, Steele JE. Bowen DM, et al. Neurobiol Aging. 1989 Sep-Oct;10(5):616-8; discussion 618-20. doi: 10.1016/0197-4580(89)90152-8. Neurobiol Aging. 1989. PMID: 2812239

9

Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.

Procter AW, Palmer AM, Francis PT, Lowe SL, Neary D, Murphy E, Doshi R, Bowen DM. Procter AW, et al. Among authors: bowen dm. J Neurochem. 1988 Mar;50(3):790-802. doi: 10.1111/j.1471-4159.1988.tb02983.x. J Neurochem. 1988. PMID: 3339353

10

Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.

Lowe SL, Francis PT, Procter AW, Palmer AM, Davison AN, Bowen DM. Lowe SL, et al. Among authors: bowen dm. Brain. 1988 Aug;111 ( Pt 4):785-99. doi: 10.1093/brain/111.4.785. Brain. 1988. PMID: 3401683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters